Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response

Background: Anakinra (ANA) is an effective treatment choice in patients with adult onset Still’s disease (AOSD). Variables affecting treatment survival include loss of efficacy or adverse events, but also the decision to discontinue treatment after long-term clinical remission. Objectives: Aims of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Vitale, Antonio, Cavalli, Giulio, Colafrancesco, Serena, Priori, Roberta, Valesini, Guido, Argolini, Lorenza Maria, Baldissera, Elena, Bartoloni, Elena, Cammelli, Daniele, Canestrari, Giovanni, Sota, Jurgen, Cavallaro, Elena, Massaro, Maria Grazia, Ruscitti, Piero, Cipriani, Paola, De Marchi, Ginevra, De Vita, Salvatore, Emmi, Giacomo, Ferraccioli, Gianfranco, Frassi, Micol, Gerli, Roberto, Gremese, Elisa, Iannone, Florenzo, Lapadula, Giovanni, Lopalco, Giuseppe, Manna, Raffaele, Mathieu, Alessandro, Montecucco, Carlomaurizio, Mosca, Marta, Piazza, Ilaria, Piga, Matteo, Pontikaki, Irene, Romano, Micol, Rossi, Silvia, Rossini, Maurizio, Silvestri, Elena, Stagnaro, Chiara, Talarico, Rosaria, Tincani, Angela, Viapiana, Ombretta, Vitiello, Gianfranco, Galozzi, Paola, Sfriso, Paolo, Gaggiano, Carla, Rigante, Donato, Dagna, Lorenzo, Giacomelli, Roberto, Cantarini, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6454864/
https://ncbi.nlm.nih.gov/pubmed/31001115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00296
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados